Lv1
38 积分 2023-02-27 加入
AGPAT4 targeted covalent inhibitor potentiates targeted therapy to overcome cancer cell plasticity in hepatocellular carcinoma mouse models
1个月前
已完结
A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma
1个月前
已完结
A new BRAF inhibitor breaks resistance barriers
3个月前
已完结
GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma
3个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
3个月前
已完结
Recent advances in bispecific natural killer cell engagers for cancer immunotherapy
4个月前
已完结
Recent advances in bispecific natural killer cell engagers for cancer immunotherapy
4个月前
已完结
Microenvironment-responsive anti-PD-L1 × CD3 bispecific T-cell engager for solid tumor immunotherapy
4个月前
已完结
Systematic profiling of tumor-associated antigen expression for antibody-drug conjugate in prostate cancer
4个月前
已完结
Advances in PET Imaging of the CXCR4 Receptor: [68Ga]Ga-PentixaFor
5个月前
已完结